Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-MS
NCT04749667Phase 2Active, not recruiting
- Sponsor
- Haukeland University Hospital
- Start
- Aug 2021
- Primary completion
- Mar 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in multiple sclerosis (MS), sponsored by Haukeland University Hospital. Started Aug 2021; status: active, not recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04749667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04749667.